These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19795194)

  • 1. Autoimmunity, infectious immunity, and atherosclerosis.
    Matsuura E; Kobayashi K; Matsunami Y; Shen L; Quan N; Makarova M; Suchkov SV; Ayada K; Oguma K; Lopez LR
    J Clin Immunol; 2009 Nov; 29(6):714-21. PubMed ID: 19795194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis in autoimmune diseases.
    Matsuura E; Kobayashi K; Lopez LR
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
    Berger JS; Rockman CB; Guyer KE; Lopez LR
    J Immunol Res; 2014; 2014():234316. PubMed ID: 25405208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K; Lopez LR; Matsuura E
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune-mediated atherothrombosis.
    Matsuura E; Lopez LR
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E; Lopez LR
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
    Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
    Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
    J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
    Zhang X; Xie Y; Zhou H; Xu Y; Liu J; Xie H; Yan J
    J Atheroscler Thromb; 2014; 21(11):1140-51. PubMed ID: 24998486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
    Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
    Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
    Kraml P
    Vnitr Lek; 2016; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.